A Critical Pathway for Management of Patients with Acute Chest Pain Who Are at Low Risk for Myocardial Ischemia: Recommendations and Potential Impact

1997 ◽  
Vol 127 (11) ◽  
pp. 996 ◽  
Author(s):  
Graham Nichol
2004 ◽  
Vol 116 (3) ◽  
pp. 83-89 ◽  
Author(s):  
Martin Schillinger ◽  
Gottfried Sodeck ◽  
Giora Meron ◽  
Karin Janata ◽  
Mariam Nikfardjam ◽  
...  

2020 ◽  
Vol 37 (11) ◽  
pp. 690-695
Author(s):  
Lane M. Smith ◽  
Nicklaus P. Ashburn ◽  
Anna C. Snavely ◽  
Jason P. Stopyra ◽  
Kristin M. Lenoir ◽  
...  

BackgroundThe HEART Pathway combines a History ECG Age Risk factor (HEAR) score and serial troponins to risk stratify patients with acute chest pain. However, it is unclear whether patients with HEAR scores of <1 require troponin testing. The objective of this study is to measure the major adverse cardiac event (MACE) rate among patients with <1 HEAR scores and determine whether serial troponin testing is needed to achieve a miss rate <1%.MethodsA secondary analysis of the HEART Pathway Implementation Study was conducted. HEART Pathway risk assessments (HEAR scores and serial troponin testing at 0 and 3 hours) were completed by the providers on adult patients with chest pain from three US sites between November 2014 and January 2016. MACE (composite of death, myocardial infarction (MI) and coronary revascularisation) at 30 days was determined. The proportion of patients with HEAR scores of <1 diagnosed with MACE within 30 days was calculated. The impact of troponin testing on patients with HEAR scores of <1 was determined using Net Reclassification Improvement Index (NRI).ResultsProviders completed HEAR assessments on 4979 patients and HEAR scores<1 occurred in 9.0% (447/4979) of patients. Among these patients, MACE at 30 days occurred in 0.9% (4/447; 95% CI 0.2% to 2.3%) with two deaths, two MIs and 0 revascularisations. The sensitivity and negative predictive value for MACE in the HEAR <1 was 97.8% (95%CI 94.5% to 99.4%) and 99.1% (95% CI 97.7% to 99.8%), respectively, and were not improved by troponin testing. Troponin testing in patients with HEAR <1 correctly reclassified two patients diagnosed with MACE, and was elevated among seven patients without MACE yielding an NRI of 0.9% (95%CI −0.7 to 2.4%).ConclusionThese data suggest that patients with HEAR scores of 0 and 1 represent a very low-risk group that may not require troponin testing to achieve a missed MACE rate <1%.Trial registration numberNCT02056964


2016 ◽  
Vol 28 ◽  
pp. 59-64 ◽  
Author(s):  
Alberto Bouzas-Mosquera ◽  
Jesús Peteiro ◽  
Francisco J. Broullón ◽  
Ignacio P. Constanso ◽  
Jorge L. Rodríguez-Garrido ◽  
...  

CHEST Journal ◽  
2002 ◽  
Vol 122 (2) ◽  
pp. 517-523 ◽  
Author(s):  
Adam Snider ◽  
Marco Papaleo ◽  
Stuart Beldner ◽  
Chong Park ◽  
Dennis Katechis ◽  
...  

2015 ◽  
Vol 187 ◽  
pp. 565-580 ◽  
Author(s):  
Jorge Romero ◽  
S. Arman Husain ◽  
Anthony A. Holmes ◽  
Iosif Kelesidis ◽  
Patricia Chavez ◽  
...  

Author(s):  
Zahid Shaikh ◽  
V. S. Shinde ◽  
Sumalya Tripathi ◽  
Dhiraj Jadhav ◽  
Ishan Lamba ◽  
...  

Chest pain is one of the most common presentation to emergency department (ED). The misdiagnosis or over-diagnosis of patients with acute chest pain can be associated with serious clinical events or is time-consuming and this places a heavy burden on overcrowded and resource constraint ED. To help overcome this issue various scores are formed to rule out acute coronary syndrome (ACS) in these patients. Those who do not meet the criteria of high risk ACS like raised cardiac biomarkers, ECG changes, etc are labeled as low risk ACS. These patients form the majority of patients. A multitude of risk score have been formulated to predict the outcome and risk stratify patients with chest pain. Our objective was to evaluate the utility of these score in Indian setting in low risk ACS patients. We studied the various risk prediction score of 100 patients presenting to the ED of tertiary care teaching institute in an urban industrial area with low risk ACS. The scores that were calculated included HEART, TIMI, ADAPT, GRACE, NACPR and EDACS. Of all the scores only the HEART score correlated well with identifying those who required further testing. Taking a score of less than 3 as a marker of low risk ACS we get a sensitivity of 95.83% (95CI - 89.67% to 98.85%) and specificity of 100%. The PPV is 100% and accuracy of 96%. All other scores were either not specific enough or had limited utility. Keywords: Low risk ACS, ACS, HEART, TIMI, ADAPT, GRACE, NACPR, EDACS


2015 ◽  
Vol 116 (2) ◽  
pp. 204-207 ◽  
Author(s):  
David E. Winchester ◽  
John Brandt ◽  
Carla Schmidt ◽  
Brandon Allen ◽  
Thomas Payton ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document